Search

everythinglearnresearchcommunity

for

Search:↓

Topical finasteride and flutamide reduce gland size and enzyme activity, with flutamide being more potent, potentially treating acne, seborrhea, hirsutism, and androgenic alopecia.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Sex hormone treatments can increase muscle mass in older adults but have inconsistent effects on muscle function and may carry cardiovascular risks.

Premature ovarian insufficiency (POI) can harm women's sexual health, and they may benefit from hormone therapy and counseling.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Early onset hair loss linked to genetics and androgen levels.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

Men with testicular cancer were less likely to experience baldness and severe acne.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Parietal scalp area has lower hair density and smaller hair diameter in women with hair loss.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Finasteride may help some women with hair loss, but better options exist.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

New resveratrol-related compounds show promise for treating various health issues but need more research for clinical use.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Ketoconazole shampoo with finasteride improves hair density in men with hair loss.

Suppressing certain hormones might help prevent prostate cancer.

Finasteride potentially treats hair loss by reducing DHT production.

Women generally handle heart enlargement better than men, but it's riskier for them if it occurs; hormones like estrogen offer some protection.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.